M
$ Value
$0
Shares
6,500
Price
$0
Filed
Jul 2
Insider
Name
Moreadith Randall
Title
Chief Scientific Officer
CIK
0001301120
Roles
Officer
Transaction Details
Transaction Date
2025-06-30
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
514,686
Footnotes
The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.68 to $6.05. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. | The stock options are fully vested.
Filing Info
Moreadith Randall's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-23 | SER | M | $390 |
| 2026-03-23 | SER | ▼ | $19K |
| 2026-03-23 | SER | M | $0 |
| 2026-03-19 | SER | M | $2K |
| 2026-03-19 | SER | ▼ | $98K |
| 2026-03-19 | SER | M | $0 |
| 2026-02-03 | SER | A | $0 |
| 2026-02-02 | SER | M | $390 |
| 2026-02-02 | SER | ▼ | $20K |
| 2026-02-02 | SER | M | $0 |
Other Insiders at SER (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
LEDGER STEVEN A
Chief Executive Officer
|
— | — | 2026-02-03 |
| GILL SIMBA | — | — | 2026-02-03 |
|
Moreadith Randall
Chief Scientific Officer
|
— | $159K | 2026-03-23 |
| Bailey Gregory | — | — | 2026-03-31 |
| Venkatesan Jay | — | — | 2026-03-31 |
|
Tenjarla Srini
SVP, CMC & Formulation
|
— | — | 2026-02-03 |